Incidence and therapy of cytomegalovirus disease after liver transplantation.
Department of Surgery, Free University of Berlin, UKRV-W, Germany.
M
M
Wiens
B
B
Lefèbre
G
G
Blumhardt
C A
CA
Schmidt
R
R
Lohmann
P
P
Neuhaus
D000212:Acyclovir / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy*; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology; D011183:Postoperative Complications / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy*; D012189:Retrospective Studies; D012307:Risk Factors
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; C045781:cytomegalovirus-specific hyperimmune globulin; D015774:Ganciclovir; D000212:Acyclovir